Copper brain homeostasis: Role of amyloid precursor protein and prion protein

IUBMB Life

Volumn 57, Issue 9, 2005, Pages 645-650

  Inestrosa, Nibaldo C ^a   Cerpa, Waldo ^a   Varela Nallar, Lorena ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

APP; Copper; Copper binding domain; Metal homeostasis; Prion protein

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CHELATING AGENT; COPPER; COPPER CHLORIDE; COPPER ZINC CHELATOR; PENICILLAMINE; PRION PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BEHAVIOR DISORDER; BINDING SITE; BRAIN; COPPER DEFICIENCY; COPPER METABOLISM; DISEASE ASSOCIATION; HOMEOSTASIS; HUMAN; MEMORY DISORDER; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRION DISEASE; PROTEIN DOMAIN; REVIEW; SPATIAL MEMORY; TRANSGENIC ANIMAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BINDING SITES; BRAIN; COPPER; HOMEOSTASIS; MICE; MICE, TRANSGENIC; PRIONS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

ANIMALIA;

EID: 27444445191     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1080/15216540500264620     Document Type: Review

References (41)

1. Hardy, J., and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
2. Atwood, C. S., Scarpa, R. C., Huang, X., Moir, R. D., Jones, W. D., Fairlie, D. P., Tanzi, R. E., and Bush, A. I. (2000) Characterization of copper interactions with Alzheimer amyloid β peptides: Identification of an attomolar-affinity copper binding site on amyloid β 1-42. J. Neurochem. 75, 1219-1233.
3. Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., White, A. R., Beyreuther, K., Masters, C. L., Bush, A. L., and Li, Q. X. (2002) Overexpression of Alzheimer's disease amyloid-β opposes the age-dependent elevations of brain copper and iron. J. Biol. Chem. 277, 44670-44676.
4. Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., and Beyreuther, K. (1996) The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science 271, 1406-1409.
5. Ruiz, F. H., Gonzalez, M., Bodini, M., Opazo, C., and Inestrosa, N. C. (1999) Cysteine 144 is a key residue in the copper reduction by the β-amyloid precursor protein. J. Neurochem. 73, 1288-1292.
6. 2+ neurotoxicity in vivo. FASEB J. 18, 1701-1703.
7. Tohgi, H., Abe, T., Yamazaki, K., Murata, T., Ishizaki, E., and Isobe, C. (1999) Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci. Lett. 269, 52-54.
8. Alvarez, J., Moreno, R. D., Llanos, O., Inestrosa, N. C., Brandan, E., Colby, T., and Esch, F. S. (1992) Axonal sprouting induced in the sciatic nerve by the amyloid precursor protein (APP) and other antiproteases. Neurosci. Lett. 144, 130-134.
9. Mattson, M. P., Cheng, B., Culwell, A. R., Esch, F. S., Lieberburg, I., and Rydel, R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10, 243-254.
10. Opazo, C., Barria, M. I., Ruiz, F. H., and Inestrosa, N. C. (2003) Copper reduction by copper binding proteins and its relation to neurodegenerative diseases. Biometals 16, 91-98.
11. Miura, T., Suzuki, K., Kohata, N., and Takeuchi, H. (2000) Metal binding modes of Alzheimer's amyloid β-peptide in insoluble aggregates and soluble complexes. Biochemistry 39, 7024-7031.
12. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52.
13. Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y., Huang, X., Goldstein, L. E., Moir, R. D., Lim, J. T., Beyreuther, K., Zheng, H., Tanzi, R. E., Masters, C. L., and Bush, A. I. (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30, 665-676.
14. 2. J. Biol. Chem. 111, 40302-40308.
15. Zou, K., Gong, J. S., Yanagisawa, K., and Michikawa, M. (2002) A novel function of monomeric amyloid β-protein sarving as an antioxidant molecule against metal induced oxidative damage. J. Neurosci. 22, 4833-4841.
16. Sparks, D. L., and Schreurs, B. G. (2003) Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 100, 11065-11069.
17. Squitti, R., Pasqualetti, P., Dal Forno, G., Moffa, F., Cassetta, E., Lupoi, D., Vernieri, F., Rossi, L., Baldassini, M., and Rossini, P. M. (2005) Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 64, 1040-1046.
18. Bayer, T. A., Schafer, S., Simons, A., Kemmling, A., Kamer, T., Tepest, R., Eckert, A., Schussel, K., Eikenberg, O., Sturchler-Pierrat, C., Abramowski, D., Staufenbiel, M., and Multhaup, G. (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice. Proc. Natl. Acad. Sci. USA 100, 14187-14192.
19. Phinney, A. L., Drisaldi, B., Schmidt, S. D., Lugowski, S., Coronado, V., Liang, Y., Horne, P., Yang, J., Sekoulidis, J., Coomaraswamy, J., Chishti, M. A., Cox, D. W., Mathews, P. M., Nixon, R. A., Carlson, G. A., St George-Hyslop, P., and Westaway, D. (2003) In vivo reduction of amyloid-β by a mutant copper transporter. Proc. Natl. Acad. Sci. USA 100, 14193-14198.
20. Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. USA 95, 13363-13383.
21. Caughey, B., and Raymond, G. J. (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J. Biol. Chem. 266, 18217-18223.
22. Kretzschmar, H. A., Prusiner, S. B., Stowring, L. E., and DeArmond, S. J. (1986) Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122, 1-5.
23. Stahl, N., Borchelt, D. R., Hsiao, K., and Prusiner, S. B. (1987) Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229-240.
24. Stockel, J., Safar, J., Wallace, A. C., Cohen, F. E., and Prusiner, S. B. (1998) Prion protein selectively binds copper(II) ions. Biochemistry 37, 7185-7193.
25. Viles, J. H., Cohen, F. E., Prusiner, S. B., Goodin, D. B., Wright, P. E., and Dyson, H. J. (1999) Copper binding to the prion protein: Structural implications of four identical cooperative binding sites. Proc. Natl. Acad. Sci. USA 96, 2042-2047.
26. Wadsworth, J. D., Hill, A. F., Joiner, S., Jackson, G. S., Clarke, A. R., and Collinge, J. (1999) Strain-specific prion-protein conformation determined by metal ions. Nat. Cell Biol. 1, 55-59.
27. Ruiz, F. H., Silva, E., and Inestrosa, N. C. (2000) The N-terminal tandem repeat region of human prion protein reduces copper: Role of tryptophan residues. Biochem. Biophys. Res. Commun. 269, 491-495.
28. Miura, T., Sasaki, S., Toyama, A., and Takeuchi, H. (2005) Copper reduction by the octapeptide repeat region of prion protein: pH dependence and implications in cellular copper uptake. Biochemistry 44, 8712-8720.
29. Chacon, M. A., Barria, M. I., Lorca, R., Huidobro-Toro, J. P., and Inestrosa, N. C. (2003) A human prion protein peptide (PrP(59-91)) protects against copper neurotoxicity. Mol. Psychiatry 8, 853-862.
30. Pauly, P. C., and Harris, D. A. (1998) Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33107-33110.
31. Rachidi, W., Vilette, D., Guiraud, P., Arlotto, M., Riondel, J., Laude, H., Lehmann, S., and Favier, A. (2003) Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J. Biol. Chem. 278, 9064-9072.
32. Varela-Nallar, E., Toledo, E., Cabrai, A. E. B., Martins, V. R., and Inestrosa, N. C. (2005) The cellular prion protein gene expression is induced by copper in neuronal cells. Am. J. Physiol. Cell. Physiol. (in revision).
33. 2+ coordination by His96 and His111 induces β-sheet formation in the unstructured amyloidogenic region of the prion protein. J. Biol. Chem. 279, 32018-32027.
34. Quaglio, E., Chiesa, R., and Harris, D. A. (2001) Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform. J. Biol. Chem. 276, 11432-11438.
35. Wong, E., Thackray, A. M., and Bujdoso, R. (2004) Copper induces increased β-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR. Biochem. J. 380, 273-282.
36. Sigurdsson, E. M., Brown, D. R., Alim, M. A., Scholtzova, H., Carp, R., Meeker, H. C., Prelli, F., Frangione, B., and Wisniewski, T. (2003) Copper chelation delays the onset of prion disease. J. Biol. Chem. 278, 46199-46202.
37. McKenzie, D., Bartz, J., Mirwald, J., Olander, D., Marsh, R., and Aiken, J. (1998) Reversibility of scrapie inactivation is enhanced by copper. J. Biol. Chem. 273, 25545-25547.
38. Kiachopoulos, S., Heske, J., Tatzeit, J., and Winklhofer, K. F. (2004) Misfolding of the prion protein at the plasma membrane induces endocytosis, intracellular retention and degradation. Traffic 5, 426-436.
39. Varela-Nallar, L., Gonzalez, A., and Inestrosa, N. C. (2005) Role of copper on prion diseases: Misfolding versus trafficking effects on prion protein. Curr. Pharm. Design (in press).
40. Ma, J., and Lindquist, S. (2002) Conversion of PrP to a self-perpetuating PrPSc-like conformation in the cytosol. Science 298, 1785-1788.
41. Hijazi, N., Shaked, Y., Rosenmann, H., Ben-Hur, T., and Gabizon, R. (2003) Copper binding to PrPC may inhibit prion disease propagation. Brain Res. 993, 192-200.